1. Randomized, Ascending Dose, Phase 2 Study of KHK4083, an Anti-OX40 Monoclonal Antibody, in Moderately Active Ulcerative Colitis. Issue 3 (9th June 2020) Authors: Kierkus, Jaroslaw; Pesegova, Marina; Klopocka, Maria; Brankovic, Marija; Kasai, Noriyuki; Efuni, Sergey; Kong, Jennifer; Nakajima, Yu; Jordan, Christina; Matsui, Takeshi; Feagan, Brian G; Strout, Vincent Journal: Crohn's & colitis 360 Issue: Volume 2:Issue 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Phase I Study of Anti-GM2 Ganglioside Monoclonal Antibody BIW-8962 as Monotherapy in Patients with Previously Treated Multiple Myeloma. Issue 2 (December 2016) Authors: Baz, Rachid; Zonder, Jeffrey; Gasparetto, Cristina; Reu, Frederic; Strout, Vincent Journal: Oncology and therapy Issue: Volume 4:Issue 2(2016) Page Start: 287 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Corrigendum to: Randomized, Ascending Dose, Phase 2 Study of KHK4083, an Anti-OX40 Monoclonal Antibody, in Moderately Active Ulcerative Colitis. Issue 4 (17th December 2020) Authors: Kierkus, Jaroslaw; Pesegova, Marina; Klopocka, Maria; Brankovic, Marija; Kasai, Noriyuki; Efuni, Sergey; Kong, Jennifer; Nakajima, Yu; Jordan, Christina; Matsui, Takeshi; Feagan, Brian G; Strout, Vincent Journal: Crohn's & colitis 360 Issue: Volume 2:Issue 4(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗